221 related articles for article (PubMed ID: 14985500)
1. Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants.
Marty FM; Cosimi LA; Baden LR
N Engl J Med; 2004 Feb; 350(9):950-2. PubMed ID: 14985500
[No Abstract] [Full Text] [Related]
2. Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazole.
Trifilio S; Singhal S; Williams S; Frankfurt O; Gordon L; Evens A; Winter J; Tallman M; Pi J; Mehta J
Bone Marrow Transplant; 2007 Sep; 40(5):451-6. PubMed ID: 17589527
[TBL] [Abstract][Full Text] [Related]
3. Breakthrough zygomycosis during voriconazole treatment for invasive aspergillosis.
Kobayashi K; Kami M; Murashige N; Kishi Y; Fujisaki G; Mitamura T
Haematologica; 2004 Nov; 89(11):ECR42. PubMed ID: 15533847
[No Abstract] [Full Text] [Related]
4. Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis.
Siwek GT; Dodgson KJ; de Magalhaes-Silverman M; Bartelt LA; Kilborn SB; Hoth PL; Diekema DJ; Pfaller MA
Clin Infect Dis; 2004 Aug; 39(4):584-7. PubMed ID: 15356827
[TBL] [Abstract][Full Text] [Related]
5. Breakthrough invasive pulmonary aspergillosis despite empirical voriconazole therapy for febrile neutropenia: case report and review of the literature.
Meyer M; Waldvogel S; Chalandon Y; Bongiovanni M; Pache JC; Van Delden C
Scand J Infect Dis; 2007; 39(8):731-3. PubMed ID: 17654353
[TBL] [Abstract][Full Text] [Related]
6. Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or intensive chemotherapy.
Trifilio SM; Bennett CL; Yarnold PR; McKoy JM; Parada J; Mehta J; Chamilos G; Palella F; Kennedy L; Mullane K; Tallman MS; Evens A; Scheetz MH; Blum W; Kontoyiannis DP
Bone Marrow Transplant; 2007 Apr; 39(7):425-9. PubMed ID: 17310132
[TBL] [Abstract][Full Text] [Related]
7. Voriconazole and sirolimus coadministration after allogeneic hematopoietic stem cell transplantation.
Marty FM; Lowry CM; Cutler CS; Campbell BJ; Fiumara K; Baden LR; Antin JH
Biol Blood Marrow Transplant; 2006 May; 12(5):552-9. PubMed ID: 16635790
[TBL] [Abstract][Full Text] [Related]
8. Sinus zygomycosis in a patient receiving voriconazole prophylaxis.
Lionakis MS; Kontoyiannis DP
Br J Haematol; 2005 Apr; 129(1):2. PubMed ID: 15801950
[No Abstract] [Full Text] [Related]
9. Breakthrough zygomycosis and voriconazole.
Pagano L; Gleissner B; Fianchi L
J Infect Dis; 2005 Oct; 192(8):1496-7; author reply 1497. PubMed ID: 16170771
[No Abstract] [Full Text] [Related]
10. Successful treatment of breakthrough Trichosporon asahii fungemia with voriconazole in a patient with acute myeloid leukemia.
Asada N; Uryu H; Koseki M; Takeuchi M; Komatsu M; Matsue K
Clin Infect Dis; 2006 Aug; 43(4):e39-41. PubMed ID: 16838224
[TBL] [Abstract][Full Text] [Related]
11. Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole.
Imhof A; Balajee SA; Fredricks DN; Englund JA; Marr KA
Clin Infect Dis; 2004 Sep; 39(5):743-6. PubMed ID: 15356792
[TBL] [Abstract][Full Text] [Related]
12. Incidence of invasive aspergillosis among allogeneic hematopoietic stem cell transplant patients receiving voriconazole prophylaxis.
Siwek GT; Pfaller MA; Polgreen PM; Cobb S; Hoth P; Magalheas-Silverman M; Diekema DJ
Diagn Microbiol Infect Dis; 2006 Jul; 55(3):209-12. PubMed ID: 16626917
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.
Neofytos D; Horn D; Anaissie E; Steinbach W; Olyaei A; Fishman J; Pfaller M; Chang C; Webster K; Marr K
Clin Infect Dis; 2009 Feb; 48(3):265-73. PubMed ID: 19115967
[TBL] [Abstract][Full Text] [Related]
14. First case of breakthrough pulmonary Aspergillus niveus infection in a patient after allogeneic hematopoietic stem cell transplantation.
Auberger J; Lass-Flörl C; Clausen J; Bellmann R; Buzina W; Gastl G; Nachbaur D
Diagn Microbiol Infect Dis; 2008 Nov; 62(3):336-9. PubMed ID: 18687556
[TBL] [Abstract][Full Text] [Related]
15. Early fatal Rhizopus infection on voriconazole prophylaxis following allogeneic stem cell transplantation.
Ustun C; Farrow S; DeRemer D; Fain H; Jillella AP
Bone Marrow Transplant; 2007 Jun; 39(12):807-8. PubMed ID: 17438583
[No Abstract] [Full Text] [Related]
16. Voriconazole is safe and effective as prophylaxis for early and late fungal infections following allogeneic hematopoietic stem cell transplantation.
Martin T; Sharma M; Damon L; Kaplan L; Guglielmo BJ; Working M; O'Malley R; Hwang J; Linker C
Transpl Infect Dis; 2010 Feb; 12(1):45-50. PubMed ID: 19793068
[TBL] [Abstract][Full Text] [Related]
17. Breakthrough fusariosis in a patient with acute lymphoblastic leukemia receiving voriconazole prophylaxis.
Cudillo L; Girmenia C; Santilli S; Picardi A; Dentamaro T; Tendas A; de Fabritiis P
Clin Infect Dis; 2005 Apr; 40(8):1212-3. PubMed ID: 15791530
[No Abstract] [Full Text] [Related]
18. [Effect of new antifungals on the etiology of invasive fungal infections: emergence, resistance and breakthrough infection].
Salavert M; Jarque I
Rev Esp Quimioter; 2006 Mar; 19(1):11-3. PubMed ID: 16688286
[No Abstract] [Full Text] [Related]
19. [Current indications for voriconazole in onco-hematological patients].
Jarque I; Sanz MA
Rev Iberoam Micol; 2007 Sep; 24(3):213-6. PubMed ID: 17874858
[TBL] [Abstract][Full Text] [Related]
20. [Update on therapy of invasive mycoses in hematology and oncology].
Maschmeyer G; Haas A; Böhme A
Dtsch Med Wochenschr; 2005 Jun; 130(22):1381-4. PubMed ID: 15915381
[No Abstract] [Full Text] [Related]
[Next] [New Search]
